Dabigatran in tumour therapy

Details Dabigatran in tumour therapy Dabigatran in tumour therapy

A - Human Necessities

61

K

A61K 31/4439 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2734809

The invention relates to the use of dabigatran etexilate of Formula (I) optionally in the form of the pharmaceutically acceptable salts thereof, as well as new medicament formulations for the treatment of tumours.

L'invention porte sur l'utilisation d'étexilate de dabigatran représenté par la Formule (I), facultativement sous la forme des sels pharmaceutiquement acceptables de celui-ci, ainsi que sur de nouvelles formulations de médicament pour le traitement de tumeurs.

Affiliated with

Also associated with

Rating

Dabigatran in tumour therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dabigatran in tumour therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dabigatran in tumour therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1406597